Safety, Tolerability and Pharmacokinetics of SP-8203

NCT01757795 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: SP-8203
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.